Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA9159 in adult bronchial asthma
NCT07324707Phase 2Recruiting
- Sponsor
- Anhui Palo Alto Pharmaceuticals
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pa9159 in asthma, sponsored by Anhui Palo Alto Pharmaceuticals. Started Oct 2025; status: recruiting.
02
Drugs
pa9159
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07324707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07324707.